Your browser doesn't support javascript.
loading
Phage-Mediated Digestive Decolonization in a Gut-On-A-Chip Model: A Tale of Gut-Specific Bacterial Prosperity.
Van Nieuwenhuyse, Brieuc; Merabishvili, Maya; Goeders, Nathalie; Vanneste, Kevin; Bogaerts, Bert; de Jode, Mathieu; Ravau, Joachim; Wagemans, Jeroen; Belkhir, Leïla; Van der Linden, Dimitri.
Afiliación
  • Van Nieuwenhuyse B; Institute of Experimental and Clinical Research, Pediatric Department (IREC/PEDI), Université Catholique de Louvain-UCLouvain, 1200 Brussels, Belgium.
  • Merabishvili M; Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium.
  • Goeders N; Transversal Activities in Applied Genomics, Sciensano, Juliette Wytsmanstraat 14, 1050 Brussels, Belgium.
  • Vanneste K; Transversal Activities in Applied Genomics, Sciensano, Juliette Wytsmanstraat 14, 1050 Brussels, Belgium.
  • Bogaerts B; Transversal Activities in Applied Genomics, Sciensano, Juliette Wytsmanstraat 14, 1050 Brussels, Belgium.
  • de Jode M; Bacterial Diseases, Sciensano, Juliette Wytsmanstraat 14, 1050 Brussels, Belgium.
  • Ravau J; Institute of Experimental and Clinical Research, Pediatric Department (IREC/PEDI), Université Catholique de Louvain-UCLouvain, 1200 Brussels, Belgium.
  • Wagemans J; Laboratory of Gene Technology, KU Leuven, 3000 Leuven, Belgium.
  • Belkhir L; Division of Internal Medicine and Infectious Disease, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain-UCLouvain, 1200 Brussels, Belgium.
  • Van der Linden D; Louvain Centre for Toxicology and Applied Pharmacology, Institute of Experimental and Clinical Research (IREC/LTAP), Université Catholique de Louvain-UCLouvain, 1200 Brussels, Belgium.
Viruses ; 16(7)2024 Jun 28.
Article en En | MEDLINE | ID: mdl-39066209
ABSTRACT
Infections due to antimicrobial-resistant bacteria have become a major threat to global health. Some patients may carry resistant bacteria in their gut microbiota. Specific risk factors may trigger the conversion of these carriages into infections in hospitalized patients. Preventively eradicating these carriages has been postulated as a promising preventive intervention. However, previous attempts at such eradication using oral antibiotics or probiotics have led to discouraging results. Phage therapy, the therapeutic use of bacteriophage viruses, might represent a worthy alternative in this context. Taking inspiration from this clinical challenge, we built Gut-On-A-Chip (GOAC) models, which are tridimensional cell culture models mimicking a simplified gut section. These were used to better understand bacterial dynamics under phage pressure using two relevant species Pseudomonas aeruginosa and Escherichia coli. Model mucus secretion was documented by ELISA assays. Bacterial dynamics assays were performed in GOAC triplicates monitored for 72 h under numerous conditions, such as pre-, per-, or post-bacterial timing of phage introduction, punctual versus continuous phage administration, and phage expression of mucus-binding properties. The potential genomic basis of bacterial phage resistance acquired in the model was investigated by variant sequencing. The bacterial "escape growth" rates under phage pressure were compared to static in vitro conditions. Our results suggest that there is specific bacterial prosperity in this model compared to other in vitro conditions. In E. coli assays, the introduction of a phage harboring unique mucus-binding properties could not shift this balance of power, contradicting previous findings in an in vivo mouse model and highlighting the key differences between these models. Genomic modifications were correlated with bacterial phage resistance acquisition in some but not all instances, suggesting that alternate ways are needed to evade phage predation, which warrants further investigation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pseudomonas aeruginosa / Bacteriófagos / Escherichia coli / Microbioma Gastrointestinal / Terapia de Fagos Límite: Humans Idioma: En Revista: Viruses Año: 2024 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pseudomonas aeruginosa / Bacteriófagos / Escherichia coli / Microbioma Gastrointestinal / Terapia de Fagos Límite: Humans Idioma: En Revista: Viruses Año: 2024 Tipo del documento: Article País de afiliación: Bélgica
...